Quantumscape Corporation
-$425.39M- Market cap
- $523.07M
- Debt
- +$22.36M
- Cash
- −$970.81M
Capital structure 96% equity / 4% debt · EV / EBITDA 0.99x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: QS stock price vs RMD: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at RMD's multiple
Needs Revenue / share.
Implied fair value · at QS's multiple
Needs QS P/S.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: QS FY 2025 (ended Dec 31, 2025) · RMD FY 2026 (ended Jun 30, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / EBITDA 0.99x
Capital structure 98% equity / 2% debt · EV / Revenue 5.68x · EV / EBITDA 15.13x
RMD carries the larger enterprise value at $32.13B against -$425.39M; QS trades on the lower EV / EBITDA multiple (0.99x vs 15.13x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
QUANTUMSCAPE CORPORATION · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ResMed Inc. · implied price per share
Bear
$145.79
Base
$173.17
Bull
$210.12
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.02x
0.10x
Net debt / EBITDA
Leverage against operating earnings
2.21x
-0.38x
Cash and equivalents
Liquid reserves on the balance sheet
$970.81M
$1.47B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$22.36M
$659.37M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.